Emanuele Di Angelantonio Selected Research

Emanuele Di Angelantonio Research Topics

Disease

25	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 12/2009
22	Coronary Disease (Coronary Heart Disease) 01/2019 - 09/2007
21	Stroke (Strokes) 05/2024 - 04/2004
10	Ischemic Stroke 11/2021 - 04/2004
9	Inflammation (Inflammations) 10/2021 - 03/2011
8	Heart Failure 12/2023 - 09/2007
8	Vascular Diseases (Vascular Disease) 11/2023 - 04/2004
8	Hypertension (High Blood Pressure) 09/2023 - 11/2004
6	Obesity 09/2023 - 01/2018
6	Myocardial Infarction 06/2023 - 09/2007
5	Atrial Fibrillation 10/2022 - 09/2007
5	Type 2 Diabetes Mellitus (MODY) 11/2021 - 04/2016
4	Diabetes Mellitus 11/2023 - 03/2008
4	Coronary Artery Disease (Coronary Atherosclerosis) 12/2022 - 12/2017
3	COVID-19 01/2022 - 11/2020
3	Thrombosis (Thrombus) 01/2022 - 08/2012
3	Thromboembolism 05/2018 - 08/2010
2	Chronic Renal Insufficiency 11/2021 - 09/2010
2	Iron Deficiencies 01/2021 - 07/2014
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2019 - 02/2013
2	Abdominal Aortic Aneurysm 12/2019 - 11/2018
2	Patent Foramen Ovale 09/2015 - 07/2004
2	Left Ventricular Dysfunction 12/2009 - 05/2005
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2023
1	Proteinuria 11/2023
1	Albuminuria 10/2023
1	Chronic Disease (Chronic Diseases) 09/2023
1	Heart Block 06/2023
1	Bundle-Branch Block (Fascicular Block) 06/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Multiple Sclerosis 01/2023
1	Hypercholesterolemia 12/2022
1	Genetic Risk Score 11/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Cognitive Dysfunction 01/2022
1	Acute Coronary Syndrome 01/2022
1	Pulmonary Embolism 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Coronavirus Infections 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2021
1	Melanoma (Melanoma, Malignant) 07/2021
1	Kidney Diseases (Kidney Disease) 07/2021

Drug/Important Bio-Agent (IBA)

12	LipidsIBA 12/2022 - 06/2008
11	Proteins (Proteins, Gene)FDA Link 10/2022 - 11/2009
7	CholesterolIBA 12/2022 - 03/2008
7	Triglycerides (Triacylglycerol)IBA 11/2022 - 03/2008
6	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2023 - 09/2007
6	Lipoprotein(a)IBA 11/2022 - 03/2008
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2012
6	C-Reactive ProteinIBA 05/2018 - 01/2010
6	HDL CholesterolIBA 01/2018 - 11/2009
5	pro-brain natriuretic peptide (1-76)IBA 10/2016 - 12/2009
4	CreatinineIBA 11/2023 - 09/2007
4	AnticoagulantsIBA 01/2022 - 08/2012
4	IronIBA 01/2021 - 07/2014
4	Lipoproteins (Lipoprotein)IBA 01/2019 - 05/2010
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2022 - 05/2015
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021 - 03/2010
3	LDL CholesterolIBA 12/2019 - 01/2019
3	oxidized low density lipoproteinIBA 12/2019 - 12/2017
3	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2017 - 05/2010
3	Glucose (Dextrose)FDA LinkGeneric 01/2013 - 03/2010
3	ApolipoproteinsIBA 06/2012 - 09/2007
2	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2023 - 10/2021
2	CalciumIBA 10/2023 - 05/2005
2	P-2 (P 2)IBA 12/2022 - 05/2010
2	LDL Receptors (LDL Receptor)IBA 12/2022 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 11/2022 - 09/2007
2	Blood Proteins (Serum Proteins)IBA 10/2022 - 11/2021
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2021 - 03/2014
2	Cholesterol Ester Transfer ProteinsIBA 12/2019 - 06/2008
2	LDL Lipoproteins (beta Lipoproteins)IBA 12/2019 - 07/2009
2	von Willebrand FactorIBA 05/2018 - 01/2013
2	TroponinIBA 01/2018 - 08/2017
2	Ferritins (Ferritin)IBA 11/2017 - 04/2016
2	EnzymesIBA 01/2017 - 05/2010
2	Natriuretic PeptidesIBA 10/2016 - 04/2004
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2014 - 03/2010
2	Fibrinogen (Factor I)FDA Link 10/2012 - 01/2010
2	OxysterolsIBA 03/2007 - 12/2005
1	DNA (Deoxyribonucleic Acid)IBA 12/2023
1	AlbuminsIBA 11/2023
1	Hydrocortisone (Cortisol)FDA LinkGeneric 09/2023
1	omega-Chloroacetophenone (Mace)IBA 06/2023
1	vedolizumabIBA 01/2023
1	Daclizumab (Zenapax)FDA Link 01/2023
1	ProteomeIBA 10/2022
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 10/2022
1	Combined Oral ContraceptivesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	VaccinesIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 12/2021
1	Carbonic Anhydrase IIIIBA 07/2021
1	Cystatin MIBA 07/2021
1	Immunoglobulin M (IgM)IBA 06/2021
1	Immunoglobulin G (IgG)IBA 06/2021

Therapy/Procedure

11	Therapeutics 05/2024 - 08/2004
3	Secondary Prevention 09/2015 - 11/2010
1	Polypharmacy 12/2022
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2022